RIPC

CONDITION

Cardiovascular

GENDER

Males

AGE GROUP

From 60

to 75 years

STATUS

Recruiting

Project Title: Role of Sympathetic Activation in Ischemia Reperfusion Injury

 

The aim of the study is to investigate the effectiveness of remote ischemic preconditioning (RIPC) in healthy male individuals. In current research, RIPC has been shown to reduce the severity of heart attacks.

Our research team will determine whether the protection of RIPC can be replicated with drugs that block this activity. It is expected that this study will demonstrate the importance of inhibiting sympathetic “fight or flight” responses with RIPC or use of medication.

If you have any of the following below, you may be eligible for the trial!

  • Don’t take any medications
  • Non-smoker

Studies Contact Form

Approved By: Research Ethics and Governance, East Metropolitan Health Services              

Clinical Trial Registry Link:


Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260